Title : Evaluation of HI 6 treatment after percutaneous VR exposure by use of a kinetic-based dynamic computer model.

Pub. Date : 2007 Apr 20

PMID : 16904808






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Presently, standard treatment includes administration of an antimuscarinic agent (e.g. atropine) and a reactivator of inhibited AChE (oxime), but is considered to be rather ineffective with certain nerve agents due to low oxime effectiveness of the currently available oximes, obidoxime and pralidoxime. Oximes acetylcholinesterase (Cartwright blood group) Homo sapiens
2 A dynamic in vitro model, which allows the calculation of AChE activities at different scenarios was developed to facilitate the definition of effective oxime concentrations and the optimization of oxime treatment of OP poisoning of humans and may furthermore be helpful by designing animal experiments. Oximes acetylcholinesterase (Cartwright blood group) Homo sapiens
3 A dynamic in vitro model, which allows the calculation of AChE activities at different scenarios was developed to facilitate the definition of effective oxime concentrations and the optimization of oxime treatment of OP poisoning of humans and may furthermore be helpful by designing animal experiments. Oximes acetylcholinesterase (Cartwright blood group) Homo sapiens
4 The model is based on a combination of enzyme kinetics (inhibition, reactivation, aging) of AChE with OP, toxicokinetics and oxime pharmacokinetics. Oximes acetylcholinesterase (Cartwright blood group) Homo sapiens